Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
{{output}}
Background: Esophagogastric junction tumor (EGJ) is a rare but fatal disease with a rapid rising incidence worldwide in the late 20 years, and it lacks a convenient and safe method for diagnosis. The present study aimed to evalua... ...
